NEW YORK, December 14, 2017 /PRNewswire/ --
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free
tailored Stock Review on PBH, SENS, NVCR, and VAR which is a click away at http://www.wallstequities.com/registration. On Wednesday, December 13, 2017, the
NASDAQ Composite ended the trading session at 6,875.80, up 0.20%; the Dow Jones Industrial Average edged 0.33% higher, to finish
at 24,585.43; and the S&P 500 closed at 2,662.85, slightly dropping 0.05%. US markets saw seven out of nine sectors finishing
the day in green and two in red. This Thursday, WallStEquities.com has initiated reports coverage on the following Medical
Appliances & Equipment equities: Prestige Brands Holdings Inc. (NYSE: PBH), Senseonics Holdings Inc. (NYSE AMER: SENS),
NovoCure Ltd (NASDAQ: NVCR), and Varian Medical Systems Inc. (NYSE: VAR). Sign up today for free and learn why our members refer
to our research coverage as the 'best out there ':http://www.wallstequities.com/registration
Prestige Brands Holdings
Tarrytown, New York headquartered Prestige Brands Holdings Inc.'s stock finished Wednesday's
session 0.85% lower at $46.55 with a total trading volume of 374,600 shares. The Company's shares
have advanced 12.25% in the last month. The stock is trading above its 50-day moving average by 2.10%. Additionally, shares of
Prestige Brands, which through its subsidiaries, markets, sells, manufactures, and distributes over-the-counter healthcare and
household cleaning products in North America, Australia, and
internationally, have a Relative Strength Index (RSI) of 57.48.
On December 04 th, 2017, research firm William Blair upgraded the Company's stock
rating from 'Market Perform' to 'Outperform'. Signing up now gives you access to the free research coverage on PBH at:
http://www.wallstequities.com/registration/?symbol=PBH
Senseonics Holdings
On Wednesday, shares in Germantown, Maryland headquartered Senseonics Holdings Inc. recorded
a trading volume of 157,124 shares. The stock ended the session 0.77% higher at $2.63. The stock is
trading above its 200-day moving average by 16.18%. Moreover, shares of Senseonics, which designs, develops, and commercializes
glucose monitoring systems for people with diabetes primarily in Europe, have an RSI of 45.01.
Get access to our top-rated research, including the free report on SENS at: http://www.wallstequities.com/registration/?symbol=SENS
NovoCure
Saint Helier, the Channel Islands-based NovoCure Ltd's shares closed the day 2.20% lower at $20.05. The stock recorded a trading volume of 1.17 million shares, which was above its three months average
volume of 1.01 million shares. The Company's shares have gained 17.60% in the last month, 122.78% over the last twelve months,
and 155.41% since the start of the year. The stock is trading above its 50-day and 200-day moving averages by 5.32% and 25.57%,
respectively. Additionally, shares of NovoCure, which engages in the development, manufacture, and commercialization of tumor
treating fields for the treatment of solid tumors, have an RSI of 56.74. Click here to subscribe for a free membership which
welcomes you with our report on NVCR at:http://www.wallstequities.com/registration/?symbol=NVCR
Varian Medical Systems
Shares in Palo Alto, California headquartered Varian Medical Systems Inc. finished 0.87%
higher at $112.42. The stock recorded a trading volume of 1.02 million shares, which was above its
three months average volume of 761.16 thousand shares. The Company's shares have advanced 37.71% over the last twelve months, and
41.40% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 5.29% and 12.28%, respectively.
Furthermore, shares of the Company, which designs, manufactures, sells, and services medical devices and software products for
treating cancer and other medical conditions worldwide, have an RSI of 64.11. Join our big investor community at Wall St.
Equities today and start so with your free report on VAR at:http://www.wallstequities.com/registration/?symbol=VAR
--
Wall St. Equities :
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular
investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent
departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a
registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks
and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES :
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@wallstequities.com.
Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the
document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information
which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to
veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you ' re
a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between
09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities